We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7867:TSETomy Company, Ltd. Analysis

Data as of 2026-06-13 - not real-time

¥2,925.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

TOMY Co. is trading at ¥2,925.5, just below its 20‑day SMA of ¥2,971.3 and slightly under the 200‑day SMA of ¥2,934.7, while the 50‑day SMA remains supportive at ¥2,803.7. The MACD histogram is negative (‑23.0) and the signal line is bearish, indicating short‑term downside pressure, and volume has been trending lower, suggesting waning buying interest. However, the RSI sits around 51, implying the stock is not yet oversold, and volatility is elevated at 41.5% over the past month, which could amplify price swings.
Fundamentally, the company posted 12% revenue growth, maintains a solid gross margin of 40%, and generates a free cash flow of ¥6.66 bn, comfortably covering its dividend payout of 48.7% with a 2.39% yield. The forward P/E of 13.6 and a price‑to‑sales ratio below 1.0 point to relative cheapness, though the DCF‑derived fair value of ¥2,173 suggests the market may be pricing in a premium. Overall, the stock appears fairly valued with a blend of growth and income attributes, but technicals warn of near‑term weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram and decreasing volume
  • Price below 20‑day SMA and near support level
  • Neutral RSI indicating limited upside momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 12% YoY revenue growth and improving forward P/E
  • Sustainable dividend yield of 2.39% with sub‑50% payout
  • Strong cash position relative to modest debt

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified global toy portfolio and brand resilience
  • Consistent free cash flow generation supporting dividends
  • Attractive valuation multiples (P/S < 1, forward P/E ~13.6)

Key Metrics & Analysis

Financial Health

Revenue Growth11.90%
Profit Margin4.32%
P/E Ratio22.3
ROE10.74%
ROA9.21%
Debt/Equity6.76
P/B Ratio2.3
Op. Cash Flow¥20.1B
Free Cash Flow¥6.7B

Technical Analysis

TrendNeutral
RSI51.0
Support¥2,742.50
Resistance¥3,239.00
MA 20¥2,971.25
MA 50¥2,803.66
MA 200¥2,934.67
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value¥2,173.14
Target Price¥3,495.00
Upside/Downside19.47%
GradeFair
TypeBlend
Dividend Yield2.39%

Risk Assessment

Beta-0.00
Volatility41.50%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.